Respiratory Acidosis

Respiratory acidosis is a primary acid-base disorder resulting from an increase in arterial PaCO₂ (>45 mmHg) due to alveolar hypoventilation, leading to acidemia (pH <7.35 in acute cases). [1-2] It develops from disorders affecting gas exchange, chest wall/respiratory muscles, or inhibition of the medullary respiratory center. [1] The following figure illustrates the pathophysiological progression from acute to chronic respiratory acidosis and the risk of posthypercapnic alkalosis with overly rapid correction.

• Key HPI questions: Onset and tempo of dyspnea, orthopnea, sleep quality (snoring, witnessed apneas, morning headaches), medication/substance use (opioids, benzodiazepines, alcohol), recent illness or infection, trauma
• Symptom characterization: Sleepiness, morning headaches, general tiredness, malaise, ankle edema, confusion [4]
• Timing: Acute (hours–days) vs. chronic (weeks–months); acute-on-chronic decompensation is common in COPD [4]
• Triggers: Infection, sedating medications, oxygen over-supplementation in CO₂ retainers, postoperative state, neuromuscular flare
• Important negatives: Absence of chest pain, hemoptysis, fever, focal neurologic deficits, toxic ingestion

• pH <7.25 — severe acidemia with high risk of cardiovascular collapse and NIV failure [5]
• Rapidly declining mental status — confusion, somnolence, or coma indicating CO₂ narcosis [2][4]
• Respiratory rate <8 or >30 with accessory muscle use, abdominal paradox, or inability to speak in full sentences [6]
• Hemodynamic instability — hypotension unresponsive to fluids [5]
• Coexistent metabolic acidemia (low base excess) — mixed acidosis portends worse outcomes [5]
• Inability to protect airway or clear secretions — absolute contraindication to NIV, mandates intubation [6]
• Late-onset hypercapnia developing after hospital admission despite primary therapy [5]

Causative medications (CNS/respiratory depression)

• Opioids, benzodiazepines, barbiturates, general anesthetics, muscle relaxants
• Excessive supplemental O₂ in chronic CO₂ retainers (blunts hypoxic drive) [4]

Treatment medications

• Inhaled bronchodilators (albuterol, ipratropium) and systemic corticosteroids for obstructive etiologies [4]
• Naloxone for opioid-induced hypoventilation; flumazenil for benzodiazepine overdose (use with caution — seizure risk)
• Acetazolamide — carbonic anhydrase inhibitor that promotes renal bicarbonate excretion, may augment ventilatory drive in chronic compensated respiratory acidosis (e.g., COPD, OHS) [7]

Contraindicated/caution

• Sodium bicarbonate is not recommended for isolated respiratory acidosis — no RCT evidence of benefit and potential risks including paradoxical intracellular acidosis and volume overload. May be considered only in mixed respiratory + metabolic acidosis or permissive hypercapnia with severe acidemia [8-10]
• Avoid sedatives, opioids, and neuromuscular blockers unless intubation is planned

• High-carbohydrate diets increase CO₂ production (RQ ~1.0 for carbohydrates vs. ~0.7 for fat); in ventilator-dependent or borderline patients, high-fat/low-carb enteral formulas may reduce CO₂ load [1]
• Adequate hydration to support mucociliary clearance
• In obesity hypoventilation syndrome (OHS), long-term weight management is a cornerstone of therapy

• Pulmonary: Dyspnea, cough, sputum production, wheezing, orthopnea, exercise intolerance
• Neurologic: Headache (especially morning), somnolence, confusion, tremor, asterixis, seizures [2]
• Cardiovascular: Peripheral edema, palpitations (arrhythmias from acidemia/hypercapnia)
• Psychiatric: Anxiety, panic, insomnia (or hypersomnia)
• Musculoskeletal: Weakness, fatigue (neuromuscular disease screening)

• Collateral: Witnessed apneas, snoring, baseline functional status, home O₂ or CPAP/BiPAP use, prior intubations, recent medication changes, substance use
• Family history: Neuromuscular diseases (muscular dystrophy, myasthenia gravis), COPD, obesity, obstructive sleep apnea [4]
• Social context: Smoking history, occupational exposures, home environment (ability to use NIV at home), access to follow-up

• COPD — most common cause of chronic respiratory acidosis [2][11]
• Obesity/OHS — restrictive physiology with blunted ventilatory drive [4]
• Neuromuscular disease — ALS, muscular dystrophy, myasthenia gravis, Guillain-Barré syndrome [4]
• CNS depression — drug overdose (opioids, benzodiazepines), stroke, brainstem lesions [2]
• Chest wall deformity — severe kyphoscoliosis [4]
• Severe asthma — status asthmaticus with air trapping
• Obstructive sleep apnea — especially when combined with obesity
• Metabolic abnormalities — severe hypokalemia, hypothyroidism (myxedema) [4]

• COPD exacerbation — most common cause; look for wheezing, prolonged expiratory phase, smoking history
• Opioid/sedative overdose — pinpoint pupils, depressed RR, toxicology screen
• Severe asthma (status asthmaticus) — rising PaCO₂ is a late and ominous sign
• Neuromuscular crisis — Guillain-Barré, myasthenic crisis; ascending weakness, bulbar symptoms
• Obesity hypoventilation syndrome — BMI >30, daytime hypercapnia, often with OSA
• Pulmonary edema (cardiogenic or ARDS) — may cause mixed respiratory failure
• Pneumothorax — sudden onset, unilateral absent breath sounds
• CNS event — brainstem stroke, intracranial hemorrhage affecting respiratory centers
• Metabolic acidosis with respiratory fatigue — distinguish from primary respiratory acidosis by ABG pattern [11]

• Prior episodes of hypercapnic respiratory failure, prior intubations
• Baseline PaCO₂ and HCO₃⁻ (critical for distinguishing acute vs. chronic vs. acute-on-chronic)
• COPD severity (GOLD stage), home O₂ use, home NIV/CPAP
• Neuromuscular diagnoses, chest wall abnormalities
• Cardiac comorbidities (heart failure, pulmonary hypertension)
• Surgical history (thoracic, abdominal — diaphragmatic dysfunction)

Vital signs

• Tachypnea (>24 in obstructive, >30 in restrictive) or paradoxically low RR in CNS depression [6]
• Tachycardia, hypertension (sympathetic response to hypercapnia), or hypotension in severe cases
• SpO₂ may be normal or low; SpO₂ does not reflect CO₂ levels

Focused exam

• Pulmonary: Wheezing, prolonged expiration, diminished breath sounds, accessory muscle use, abdominal paradox (diaphragm fatigue)
• Neurologic: Altered mental status, asterixis, papilledema (from cerebral vasodilation), tremor [2]
• Cardiovascular: Bounding pulses, flushed skin, peripheral edema, elevated JVP (cor pulmonale) [4]
• Musculoskeletal: Proximal weakness, kyphoscoliosis, obesity habitus

Essential

• Arterial blood gas (ABG) — gold standard; defines pH, PaCO₂, PaO₂, HCO₃⁻, base excess [4]
  • Acute: HCO₃⁻ rises ~1 mEq/L per 10 mmHg rise in PaCO₂
  • Chronic: HCO₃⁻ rises ~3.5–4 mEq/L per 10 mmHg rise in PaCO₂ [12]
• Venous blood gas (VBG) — reasonable screen; venous PCO₂ correlates with arterial values and can rule out significant hypercarbia [4]
• Basic metabolic panel — serum HCO₃⁻, electrolytes (K⁺, Cl⁻), BUN/Cr, glucose
• CBC — infection screening
• Lactate — assess tissue perfusion

Situational

• Toxicology screen — if overdose suspected
• TSH — if myxedema suspected
• BNP/NT-proBNP — if heart failure contributing
• Phosphate, magnesium — neuromuscular function

• Chest X-ray — first-line; evaluate for pneumonia, pulmonary edema, pneumothorax, pleural effusion, hyperinflation (COPD), kyphoscoliosis [2]
• CT chest — if PE suspected, mass lesion, or CXR inconclusive
• CT head — if CNS etiology suspected (brainstem stroke, hemorrhage)
• Imaging is unnecessary if the etiology is clearly established (e.g., known opioid overdose with response to naloxone)

• A-a gradient — helps distinguish intrinsic lung disease (elevated A-a gradient) from pure hypoventilation (normal A-a gradient) [13]
• Pulmonary function tests (PFTs) — outpatient; assess severity of obstructive/restrictive disease
• Negative inspiratory force (NIF) and vital capacity — bedside assessment of neuromuscular respiratory reserve (NIF worse than −20 cmH₂O or VC <15 mL/kg suggests impending respiratory failure)
• Polysomnography — outpatient for suspected OSA/OHS
• Point-of-care ultrasound — diaphragm excursion, B-lines (pulmonary edema), pleural effusion, cardiac function

• Indications: All patients with acute respiratory acidosis to assess for arrhythmia and cardiac comorbidity
• Findings to watch for:
  • Sinus tachycardia (most common)
  • Atrial fibrillation (associated with worse outcomes in COPD exacerbation) [5]
  • Right heart strain pattern (P pulmonale, right axis deviation, RV hypertrophy) — suggests chronic cor pulmonale
  • Peaked T waves — hyperkalemia from severe acidemia
  • Widened QRS or arrhythmias — severe acidemia (pH <7.1)

Severity stratification

• Mild: pH 7.30–7.35, PaCO₂ 45–60 mmHg — may respond to medical therapy alone
• Moderate: pH 7.25–7.30, PaCO₂ 60–80 mmHg — strong indication for NIV [5]
• Severe: pH <7.25 — high risk of NIV failure, prepare for intubation [5]

Acute vs. chronic vs. acute-on-chronic

• Acute: SBE = 0 ± 2 mEq/L (no renal compensation yet) [12]
• Chronic: SBE = 0.4 × (PaCO₂ − 40); HCO₃⁻ elevated proportionally [12]
• Acute-on-chronic: Compensation present but insufficient for degree of hypercapnia — most common ED presentation in COPD [4]

Complications: CO₂ narcosis, cardiac arrhythmias, cardiovascular collapse, posthypercapnic metabolic alkalosis (if corrected too rapidly) [3]

Initial stabilization

• Airway assessment — if unable to protect airway → intubate
• Controlled oxygen therapy — target SpO₂ 88–92% in known CO₂ retainers; avoid high-flow O₂ which may worsen hypercapnia [14]

Non-invasive ventilation (NIV)

• First-line for acute hypercapnic respiratory failure with pH <7.35 and PaCO₂ >45 mmHg [5-6]
• BiPAP: typical starting settings IPAP 10–12 cmH₂O, EPAP 4–5 cmH₂O; titrate to clinical response
• Repeat ABG at 1–2 hours to assess response; improvement in pH and PaCO₂ expected [4]
• Contraindications to NIV: Cardiac/respiratory arrest, inability to protect airway, copious secretions, hemodynamic instability, facial trauma/surgery [6]

Etiology-directed therapy

• COPD exacerbation: Bronchodilators (albuterol/ipratropium), systemic corticosteroids, antibiotics if indicated [4]
• Opioid overdose: Naloxone 0.4–2 mg IV, repeat as needed
• Neuromuscular crisis: Urgent neurology consultation; plasmapheresis/IVIG for myasthenic crisis or GBS
• Status asthmaticus: Aggressive bronchodilators, IV magnesium, consider ketamine for sedation if intubating

Invasive mechanical ventilation

• If NIV fails (worsening pH, rising PaCO₂, declining mental status) or contraindicated
• In chronic hypercapnia, target the patient's baseline PaCO₂, not normal values — rapid correction risks posthypercapnic alkalosis [3]

Sodium bicarbonate: Not recommended for isolated respiratory acidosis; may be considered for mixed respiratory + metabolic acidosis with severe acidemia [8][10]

Acetazolamide: May be used as adjunct in chronic compensated respiratory acidosis to promote bicarbonate excretion and augment ventilatory drive [7]

• ICU admission: pH <7.25, hemodynamic instability, altered mental status, need for intubation, NIV failure, rapidly worsening trajectory [5][15]
• Stepdown/telemetry admission: pH 7.25–7.35 on NIV with improving trend, stable hemodynamics, new supplemental O₂ requirement [15]
• Observation: Mild respiratory acidosis responding to medical therapy, stable on room air or baseline O₂
• Discharge: Rarely appropriate for acute respiratory acidosis; consider only if etiology is fully reversed (e.g., opioid overdose with sustained response to naloxone, no recurrence after observation period), patient returns to baseline, and reliable follow-up is ensured [15]
• Specialist consultation triggers: Pulmonology (COPD, OHS, neuromuscular disease), neurology (GBS, myasthenic crisis), toxicology (complex overdose), palliative care (end-stage disease)

• Follow-up timing: Pulmonology or PCP within 1–2 weeks of discharge; sooner if on new home NIV [15]
• Return precautions — instruct patients to return immediately for:
  • Worsening shortness of breath or inability to speak in full sentences
  • Increasing drowsiness, confusion, or difficulty waking
  • New or worsening swelling in legs
  • Fever or worsening cough with colored sputum
• Patient counseling:
  • Smoking cessation (if applicable) [15]
  • Medication adherence (inhalers, home NIV)
  • Avoid sedating medications unless prescribed
  • Weight management in OHS
• Expected recovery: Acute respiratory acidosis from reversible causes (e.g., COPD exacerbation) typically improves within 24–72 hours with appropriate therapy; chronic respiratory acidosis requires long-term management of the underlying condition

1. Respiratory Acidosis and Respiratory Alkalosis: Core Curriculum 2023. — Palmer BF, Clegg DJ. American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation. 2023.

2. Respiratory Acidosis. — Epstein SK, Singh N. Respiratory Care. 2001.

3. Management of Life-Threatening Acid–Base Disorders. — Adrogué HJ, Madias NE. The New England Journal of Medicine. 1998.

4. Peripheral Venous Blood Gas Analysis for the Diagnosis of Respiratory Failure, Hypercarbia and Metabolic Disturbance in Adults. — Byrne AL, Pace NL, Thomas PS, et al. The Cochrane Database of Systematic Reviews. 2025.

5. Beyond the Guidelines for Non-Invasive Ventilation in Acute Respiratory Failure: Implications for Practice. — Bourke SC, Piraino T, Pisani L, Brochard L, Elliott MW. The Lancet. Respiratory Medicine. 2018.

6. Non-Invasive Ventilation in Acute Respiratory Failure. — Nava S, Hill N. Lancet. 2009.

7. Carbonic Anhydrase Inhibitors for Hypercapnic Ventilatory Failure in Chronic Obstructive Pulmonary Disease. — Jones PW, Greenstone M. The Cochrane Database of Systematic Reviews. 2001.

8. Sodium Bicarbonate Therapy for Acute Respiratory Acidosis. — Chand R, Swenson ER, Goldfarb DS. Current Opinion in Nephrology and Hypertension. 2021.

9. Acid-Base Disorders in the Critically Ill Patient. — Achanti A, Szerlip HM. Clinical Journal of the American Society of Nephrology : CJASN. 2023.

10. Alkali Therapy for Respiratory Acidosis: A Medical Controversy. — Adrogué HJ, Madias NE. American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation. 2020.

11. Acid-Base Interpretation: A Practical Approach. — Morikawa MJ, Ganesh PR. American Family Physician. 2025.

12. Diagnostic Use of Base Excess in Acid–Base Disorders. — Berend K. The New England Journal of Medicine. 2018.

13. Physiological Approach to Assessment of Acid–Base Disturbances. — Berend K, de Vries AP, Gans RO. The New England Journal of Medicine. 2014.

14. Management of Severe COPD. — Wouters EF. Lancet. 2004.

15. Acute Care of Patients With Moderate Respiratory Distress: Recommendations From an American College of Emergency Physicians Expert Panel. — Baugh CW, Neuenschwander JF, Lenox J, et al. The Western Journal of Emergency Medicine. 2025.